|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Acumen Pharmaceuticals, Inc. (ABOS) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
60,080,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Acumen Pharmaceuticals discovers and develops targeted therapies for the treatment of Alzheimer's disease. Co.'s primary drug candidate, ACU193, is a humanized monoclonal antibody which selectively targets amyloid-beta oligomers. Co. holds exclusive rights to the program.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
5,161,290 |
| Total Buy Value |
$0 |
$0 |
$0 |
$39,999,998 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
146,066 |
146,066 |
222,347 |
| Total Sell Value |
$0 |
$258,984 |
$258,984 |
$652,995 |
| Total People Sold |
0 |
5 |
5 |
6 |
| Total Sell Transactions |
0 |
11 |
11 |
17 |
| End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Porter Derrell |
Director |
– • – |
2025-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
12,800 |
12,800 |
|
- |
|
| Shah Rajeev M. |
Director |
– • • |
2025-06-04 |
4 |
A |
$0.00 |
$0 |
I/I |
12,800 |
12,800 |
|
- |
|
| Drapkin Kimberlee C |
Director |
– • – |
2025-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
12,800 |
12,800 |
|
- |
|
| Stalfort Sean |
Director |
– • – |
2025-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
12,800 |
185,124 |
|
- |
|
| Ives Jeffrey L. |
Director |
– • – |
2025-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
12,800 |
12,800 |
|
- |
|
| Stoppel Laura |
Director |
– • – |
2025-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
12,800 |
12,800 |
|
- |
|
| Fountain Nathan B |
Director |
– • – |
2025-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
12,800 |
19,050 |
|
- |
|
| Zuga Matt |
CFO & Chief Business Officer |
• – – |
2025-01-23 |
4 |
AS |
$1.72 |
$49,633 |
D/D |
(28,902) |
231,744 |
|
- |
|
| Barton Russell |
Chief Operating Officer |
• – – |
2025-01-21 |
4 |
AS |
$1.61 |
$4,692 |
D/D |
(2,914) |
136,117 |
|
- |
|
| Meisner Derek M |
Chief Legal Officer & Corp Sec |
• – – |
2025-01-21 |
4 |
AS |
$1.59 |
$5,435 |
D/D |
(3,418) |
161,127 |
|
- |
|
| Siemers Eric |
Chief Medical Officer |
• – – |
2025-01-21 |
4 |
AS |
$1.59 |
$5,118 |
D/D |
(3,219) |
170,298 |
|
- |
|
| Oconnell Daniel Joseph |
Chief Executive Officer |
• • – |
2025-01-21 |
4 |
AS |
$1.59 |
$20,102 |
D/D |
(12,619) |
667,488 |
|
- |
|
| Zuga Matt |
CFO & Chief Business Officer |
• – – |
2025-01-21 |
4 |
AS |
$1.60 |
$6,986 |
D/D |
(4,364) |
260,646 |
|
- |
|
| Oconnell Daniel Joseph |
Chief Executive Officer |
• • – |
2025-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
225,400 |
680,107 |
|
- |
|
| Barton Russell |
Chief Operating Officer |
• – – |
2025-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
49,800 |
139,031 |
|
- |
|
| Zuga Matt |
CFO & Chief Business Officer |
• – – |
2025-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
66,800 |
265,010 |
|
- |
|
| Meisner Derek M |
Chief Legal Officer & Corp Sec |
• – – |
2025-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
66,800 |
164,545 |
|
- |
|
| Schacterle Amy |
Chief Regulatory Officer |
• – – |
2025-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
8,800 |
8,800 |
|
- |
|
| Siemers Eric |
Chief Medical Officer |
• – – |
2025-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
66,800 |
173,517 |
|
- |
|
| Doherty James J. |
President and CDO |
• – – |
2025-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
62,600 |
62,600 |
|
- |
|
| Barton Russell |
Chief Operating Officer |
• – – |
2025-01-03 |
4 |
AS |
$1.86 |
$14,225 |
D/D |
(7,636) |
89,231 |
|
- |
|
| Zuga Matt |
CFO & Chief Business Officer |
• – – |
2025-01-03 |
4 |
AS |
$1.84 |
$24,367 |
D/D |
(13,235) |
198,210 |
|
- |
|
| Meisner Derek M |
Chief Legal Officer & Corp Sec |
• – – |
2025-01-03 |
4 |
AS |
$1.84 |
$20,506 |
D/D |
(11,122) |
97,745 |
|
- |
|
| Siemers Eric |
Chief Medical Officer |
• – – |
2025-01-03 |
4 |
AS |
$1.85 |
$20,047 |
D/D |
(10,859) |
106,717 |
|
- |
|
| Oconnell Daniel Joseph |
Chief Executive Officer |
• • – |
2025-01-03 |
4 |
AS |
$1.84 |
$87,873 |
D/D |
(47,778) |
454,707 |
|
- |
|
62 Records found
|
|
Page 1 of 3 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
